C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
11/2002
11/28/2002	WO2002094879A1 Antibodies specific for cd44v6
11/28/2002	WO2002094874A2 Internalisation of virus into cells
11/28/2002	WO2002094868A2 Staphylococcus aureus proteins and nucleic acids
11/28/2002	WO2002094865A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology
11/28/2002	WO2002094852A2 Taci-immunoglobulin fusion proteins
11/28/2002	WO2002094313A2 Vaccine composition
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002054065A3 Reversible mhc multimer staining for functional purification of antigen-specific t cells
11/28/2002	WO2001098360A3 Gp354 nucleic acids and polypeptides
11/28/2002	WO2001096393A9 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/28/2002	WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002	WO2001059459A3 Compositions and methods for screening therapeutic agents
11/28/2002	US20020177552 Colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions; alternatively, antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a
11/28/2002	US20020177189 Novel fluorescent proteins
11/28/2002	US20020177158 Detection of preferential protein in sample; obtain pool of proteins, incubate with probe, detect signal from probe, recover proteins
11/28/2002	US20020176856 Administering an antibody to the mammal, that binds with a specified target epitope of an antigen, associated with a tumor or an infectious agent; having engineered glycosylation site in the constant region of the heavy chain antibodies
11/28/2002	US20020176851 Aministering to mammal an effective amount of therapeutic cells, expressing a membrane-bound, proteinaceous chimeric receptor, capable recognizing and binding target cell or infective agent; antitumor therapy
11/28/2002	DE10122140A1 Rekombinante Fusionsproteine und deren Trimere Recombinant fusion proteins and their trimers
11/28/2002	CA2450677A1 A novel intein and uses thereof
11/28/2002	CA2448092A1 Internalisation of virus into cells
11/28/2002	CA2447799A1 Emission ratiometric indicators of phosphorylation
11/28/2002	CA2447616A1 Vaccine composition
11/28/2002	CA2447313A1 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002	CA2443437A1 Antibodies specific for cd44v6
11/28/2002	CA2440368A1 Staphylococcus aureus proteins and nucleic acids
11/27/2002	EP1260521A2 Immunoglobulin variants for specific Fc epsilon receptors
11/27/2002	EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor
11/27/2002	EP1259627A2 Heterologous expression of neisserial proteins
11/27/2002	EP1259626A2 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
11/27/2002	EP1259614A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2002	EP1259609A2 Human schizophrenia gene
11/27/2002	EP1259608A1 Modified fluorescent proteins
11/27/2002	EP1259597A2 Zinc finger domains and methods of identifying same
11/27/2002	EP1259595A2 Integrin antagonists
11/27/2002	EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002	EP1259542A2 Reagents and methods useful for detecting diseases of the breast
11/27/2002	EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002	CN1382158A Multiple cytokine-antibody complexes
11/27/2002	CN1382157A Therapeutic compounds comprised of anti-FC receptor binding agents
11/27/2002	CN1382156A PABLO polypeptide that interacts with BCL-XL and uses related thereto
11/27/2002	CN1382153A 重组亚单位疫苗 Recombinant subunit vaccine
11/27/2002	CN1381583A Human papillomavirus E6/E7 fusion gene and its efficient expression carrier and fusion protein vaccine
11/26/2002	US6485904 DNA encoding a plasminogen activating protein
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2087164C Target specific antibody-superantigen conjugates and their preparation
11/26/2002	CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092771A2 Specific binding proteins and uses thereof
11/21/2002	WO2002092625A2 Moraxella(branhamella) catarrhalis antigens
11/21/2002	WO2002092620A2 Peptides and related molecules that bind to tall-1
11/21/2002	WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002	WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002	WO2002018637A3 Diagnosis and treatment of prostate cancer
11/21/2002	US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002	US20020173626 Fusion protein for use in the diagnosis, prevention and treatment of liver disorders
11/21/2002	US20020173621 Generation of preferential fusion protein; obtain cell, transform with expression vector coding fusion polypeptide, propagate, express vector, recover fusion protein
11/21/2002	US20020173461 Methods for enhancing the efficacy of cancer therapy
11/21/2002	US20020173049 Controlling protein levels in eucaryotic organisms
11/21/2002	US20020173019 Enzymes for biopolymer production
11/21/2002	US20020173006 Generating chimeric zinc finger protein; obtain nucleotide sequences coding chimeric protein, transform cells, express nucleotide sequences, recover protein
11/21/2002	US20020172674 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth
11/21/2002	US20020172673 Method for down-regulating IgE
11/21/2002	US20020172660 For therapy of cancer, viral infections
11/21/2002	CA2447139A1 Specific binding proteins and uses thereof
11/21/2002	CA2447017A1 Moraxella(branhamella) catarrhalis antigens
11/21/2002	CA2429718A1 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/20/2002	EP1257654A1 M cell directed vaccines
11/20/2002	EP1257653A2 Phosphodiesterase type 7b
11/20/2002	EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof
11/20/2002	EP1257573A2 New transcription factor carp-2
11/20/2002	EP1257565A1 Mucin-1 derived antigens and their use in immunotherapy
11/20/2002	EP0758394B1 Bifunctional protein, preparation and use
11/20/2002	CN1380341A Single-stranded cyctic trispecific antibody
11/19/2002	US6482929 Antibodies to ARF-p19
11/19/2002	US6482928 Fab′-epitope complex from HIV-1 cross-neutralizing monoclonal antibody 2F5
11/19/2002	US6482927 Chimeric proteins comprising the extracellular domain of murine Ob receptor
11/19/2002	US6482925 Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482614 Stress proteins and uses therefor
11/19/2002	US6482607 Expression vector for use in a one-step purification protocol
11/19/2002	US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002	CA1341398C Expression of biologically active pdgf analogs in eucaryotic cells
11/14/2002	WO2002092769A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002	WO2002090553A2 Recombinant fusion proteins and the trimers thereof
11/14/2002	WO2002090542A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090495A2 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	WO2002090300A2 Nucleic acids and proteins with thioredoxin reductase activity
11/14/2002	WO2002089747A2 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	WO2002074904A3 Rearranged squamous cell carcinoma antigen genes ii
11/14/2002	WO2002072605A3 Expression technology for proteins containing a hybrid isotype antibody moiety
11/14/2002	WO2002066628A3 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
11/14/2002	WO2001019842A9 Subunit optimized fusion proteins
11/14/2002	US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002	US20020168712 Molecules designated LDCAM
11/14/2002	US20020168376 Plant extracts; sensitization of an animal; screening
11/14/2002	US20020168375 Biosynthetic binding proteins for immuno-targeting
11/14/2002	US20020168367 Novel immunoadhesins for treating and preventing viral and bacterial diseases

1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 295